The clinical research organization (CRO) market in India has experienced notable growth in recent years, and this trend is expected to continue. The expansion can be attributed to evolving regulatory frameworks, a thriving startup culture, and an increasing focus on specialized research areas beyond traditional drug development. However, medical devices, in-vitro diagnostics (IVDs), and public health studies are often overshadowed by the broader emphasis on pharmaceuticals, yet they hold significant potential for innovation and impact. The updated medical device regulations in India, introduced in 2017, have catalyzed this momentum, creating an environment ripe for new and innovative medical solutions. It is here that companies like Proclin Research can help organizations traverse their clinical development program.
Proclin Research is a CRO that specializes in clinical trials and research services, focusing on niche areas such as medical devices, in-vitro diagnostics (IVDs), ophthalmology, and public health studies, with a strong emphasis on innovative and cost-effective solutions for both domestic and international markets. While it does conduct drug trials, its core expertise lies in these niche fields. “We actively collaborate with clinical-stage organizations from the U.S., Israel, Singapore, and Europe, offering support for the development and testing of their medical devices, IVD products, and public health studies", says Mukul Maurya, director at Proclin Research. The approach enables the company to cater to a rapidly evolving market, fueled by a culture of innovation.
Beyond its core areas, Proclin also supports real-world evidence and phase III drug studies, particularly for nutraceuticals, catering to organizations looking to export high-quality products from India. A dedicated team manages nutraceutical studies, ensuring comprehensive support for this segment. In addition, it operates a division focused on the cosmetic industry, addressing the growing demand for clinical testing of products such as moisturizers, soaps, creams, hydration solutions, and shampoos.
Expertise, Innovation, and Strategic Expansion
Proclin Research’s commitment to client satisfaction is evident in its realistic approach to timelines and deliverables. The firm relies on its experienced team, many of whom have over 20 years of industry expertise, to provide accurate and achievable timelines. This helps manage client expectations effectively, ensuring that projects are completed on time while maintaining the highest quality standards. Its comprehensive client engagement process, spanning business development, technical consultation, and scientific advising, ensures that clients receive tailored support from project inception through completion. By utilizing in-house data analytics platforms, it continually monitors and identifies potential risks, keeping clients informed and prepared to address any issues that may arise.
Proclin relies on its experienced team, many of whom have more than 20 years of industry expertise, to provide accurate and achievable timelines
The firm’s robust network, comprising more than 350 sites across India with formal agreements in place with more than 70 of them, provides a solid foundation for its clinical operations. The network is maintained on a cloud-based platform, facilitating quick and efficient site selection and collaboration. In addition, its focus on cost-effective solutions, combined with a strong emphasis on scientific writing and publication, reinforces its competitive position in the market.
With its headquarters in Bhopal, Madhya Pradesh, Proclin has effectively tapped into the central region of India, an area traditionally underserved by CROs. The strategic choice has enabled the company to collaborate closely with local government bodies to address the specific disease burden in the region. Its expansion into Delhi, Bangalore, and Raipur further strengthens its presence, allowing it to manage international projects while maintaining a strong local foothold. By continuing to focus on innovative and high-growth areas such as medical devices, IVDs, and public health, Proclin is poised to make significant contributions to the evolving landscape of clinical research within India and on the global stage.
